Skip to main content
. 2017 Oct 24;1(23):2105–2114. doi: 10.1182/bloodadvances.2017006866

Figure 3.

Figure 3.

Emaxdose-response relationship between daratumumab exposure and maximum reduction in NK cells. (A) Maximum percent reduction of NK cells from baseline by dose and (B) recovery rate of NK cells from nadir relative to baseline. The centered curves and shaded areas represent predicted average Emax curves and the 95% confidence interval around the Emax curves, respectively.